Important update: Healthcare facilities
CDC has updated select ways to operate healthcare systems effectively in response to COVID-19 vaccination. Learn more
Given new evidence on the B.1.617.2 (Delta) variant, CDC has updated the guidance for fully vaccinated people. CDC recommends universal indoor masking for all teachers, staff, students, and visitors to K-12 schools, regardless of vaccination status. Children should return to full-time in-person learning in the fall with layered prevention strategies in place.
The White House announced that vaccines will be required for international travelers coming into the United States, with an effective date of November 8, 2021. For purposes of entry into the United States, vaccines accepted will include FDA approved or authorized and WHO Emergency Use Listing vaccines. More information is available here.
Travel requirements to enter the United States are changing, starting November 8, 2021. More information is available here.

What You Need to Know about Variants

What You Need to Know about Variants

Omicron Variant

No cases of this variant have been identified in the U.S. to date. CDC is following the details of this new variant. See CDC’s Media Statement.

viruses icon

Discussions about the Delta Variant: Viruses constantly change through mutation. Some variants emerge and disappear while others may emerge and persist. New variants will continue to emerge. CDC and other public health organizations monitor all variants of the virus that causes COVID-19 in the United States and globally.

The Delta variant causes more infections and spreads faster than earlier forms of the virus that causes COVID-19. Vaccines continue to reduce a person’s risk of contracting the virus that causes COVID-19, including this variant. Vaccines are also highly effective against severe illness.

Top Things You Need to Know

  1. New variants of the virus are expected to occur. Taking measures to reduce the spread of infection, including getting a COVID-19 vaccine, is the best way to slow the emergence of new variants.
  2. Vaccines reduce your risk of severe illness, hospitalization, and death from COVID-19.
  3. All COVID-19 tests can detect known variants, but they will not tell you which variant you have.
viruses light icon


  • FDA approved or authorized COVID-19 vaccines protect against Delta and other known variants.
  • Vaccines reduce your risk of severe illness, hospitalization, and death from COVID-19.
  • We don’t yet know how effective the vaccines will be against new variants that may arise.
lungs virus light icon


  • All variants cause similar COVID-19 symptoms.
  • Some variants, such as the Alpha and Delta variants, may cause more severe illness and death.
head side mask light icon


  • Wearing a mask is an effective way to reduce the spread of earlier forms of the virus, the Delta variant and other known variants.
  • People who are not fully vaccinated should to take steps to protect themselves, including wearing a mask indoors in public at all levels of community transmission.
  • People who have an underlying medical condition, a weakened immune system, or are taking medications that weaken their immune system may not have as much protection even if they are fully vaccinated. They should continue to take steps recommended for people who are not fully vaccinated, including wearing a mask.
vials light icon


  • Tests used to diagnose COVID-19 may not tell you which variant you have.
  • Tests can detect new variants. As new variants emerge, scientists will continue to evaluate how well tests work to detect current infection.

Types of Variants

Scientists monitor all variants but may classify certain ones as Variants Being Monitored, Variants of Concern, Variants of Interest or Variants of High Consequence. Some variants seem to spread more easily and quickly than other variants, which may lead to more cases of COVID-19. An increase in the number of cases will put more strain on healthcare resources, lead to more hospitalizations, and potentially more deaths.

These classifications are based on how easily the variant spreads, how severe the symptoms are, how the variant responds to treatments, or how well vaccines protect against the variant.

Variants of Concern in the US

illustration of virus in green

Delta - B.1.617.2

First identified: India

Spread: Spreads more easily than other variants.

Severe illness and death: May cause more severe cases than the other variants

Vaccine: Vaccine breakthrough infections are expected, but vaccines are effective at preventing most infections. Infections happen in only a small proportion of people who are fully vaccinated, even with the Delta variant. Early evidence suggests that fully vaccinated people who become infected with the Delta variant can spread the virus to others. All FDA-approved or authorized vaccines are particularly effective against severe illness, hospitalization, and death.

Treatments: Nearly all variants circulating in the United States respond to treatment with FDA-authorized monoclonal antibody treatments.